Loading…

Pulmonary Function Tests in Preschool Children with Cystic Fibrosis

Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90-130 cm; 16 homozygous Delta F508) and in 79 healthy control children. Functional...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2002-10, Vol.166 (8), p.1099-1104
Main Authors: Beydon, Nicole, Amsallem, Francis, Bellet, Mireille, Boule, Michele, Chaussain, Michele, Denjean, Andre, Matran, Regis, Pin, Isabelle, Alberti, Corinne, Gaultier, Claude
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3
cites cdi_FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3
container_end_page 1104
container_issue 8
container_start_page 1099
container_title American journal of respiratory and critical care medicine
container_volume 166
creator Beydon, Nicole
Amsallem, Francis
Bellet, Mireille
Boule, Michele
Chaussain, Michele
Denjean, Andre
Matran, Regis
Pin, Isabelle
Alberti, Corinne
Gaultier, Claude
description Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90-130 cm; 16 homozygous Delta F508) and in 79 healthy control children. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (Rint(exp)) (interrupter technique) were measured. As compared with control children, children with CF had significantly higher Rint(exp), expressed as absolute values and as Z-scores (1.05 +/- 0.36 versus 0.80 +/- 0.20 kPa.L(-1). second, p < 0.0001; and 1.31 +/- 1.72 versus 0.19 +/- 0.97, p < 0.0001), and significantly lower specific expiratory interrupter conductance (1.29 +/- 0.34 versus 1.63 +/- 0.43 kPa(-1). second, p < 0.0001). The effect of the bronchodilator salbutamol on Rint(exp) was not significantly different between children with CF and control children. Rint(exp) Z-scores were significantly higher in children with CF who were exposed to passive smoke (n = 8) (p < 0.03). Children with CF and with a history of respiratory symptoms (n = 31) had significantly higher functional residual capacity Z-scores (p < 0.02) and lower specific expiratory interrupter conductance Z-scores (p < 0.04). Genotype did not influence the data. We conclude that Rint(exp) and functional residual capacity measurements may help to follow young children with CF who are unable to perform reproducible forced expiratory maneuvers.
doi_str_mv 10.1164/rccm.200205-421OC
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1164_rccm_200205_421OC</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12379554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotlZ_gBfJxYuwNdlks81RFqtCoT1U8Bay-XBT9qMkW0r_vVm30NPMwPPODA8AjxjNMWb01SvVzFOEUpQlNMXr4gpMcUbiwHN0HXuUk4RS_jMBdyHsEMLpAqNbMMEpyXmW0SkoNoe66VrpT3B5aFXvuhZuTegDdC3ceBNU1XU1LCpXa29aeHR9BYtT6J2CS1f6LrhwD26srIN5ONcZ-F6-b4vPZLX--CreVokinPSJlJohqzMpKVeWp4uMWGOYRjo3hueEYWpTjDjJWUZKLi2TVEeQGU1wSUoyA3jcq-LZ4I0Ve--a-LrASAxCxCBEjELEv5CYeRoz-0PZGH1JnA1E4PkMyKBkbb1slQsXjvCc8nTgXkaucr_V0XkjQiPrOq7FQu6Gw5gxsYivcE7-ACbleSM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pulmonary Function Tests in Preschool Children with Cystic Fibrosis</title><source>Freely Accessible Science Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Beydon, Nicole ; Amsallem, Francis ; Bellet, Mireille ; Boule, Michele ; Chaussain, Michele ; Denjean, Andre ; Matran, Regis ; Pin, Isabelle ; Alberti, Corinne ; Gaultier, Claude</creator><creatorcontrib>Beydon, Nicole ; Amsallem, Francis ; Bellet, Mireille ; Boule, Michele ; Chaussain, Michele ; Denjean, Andre ; Matran, Regis ; Pin, Isabelle ; Alberti, Corinne ; Gaultier, Claude</creatorcontrib><description><![CDATA[Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90-130 cm; 16 homozygous Delta F508) and in 79 healthy control children. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (Rint(exp)) (interrupter technique) were measured. As compared with control children, children with CF had significantly higher Rint(exp), expressed as absolute values and as Z-scores (1.05 +/- 0.36 versus 0.80 +/- 0.20 kPa.L(-1). second, p < 0.0001; and 1.31 +/- 1.72 versus 0.19 +/- 0.97, p < 0.0001), and significantly lower specific expiratory interrupter conductance (1.29 +/- 0.34 versus 1.63 +/- 0.43 kPa(-1). second, p < 0.0001). The effect of the bronchodilator salbutamol on Rint(exp) was not significantly different between children with CF and control children. Rint(exp) Z-scores were significantly higher in children with CF who were exposed to passive smoke (n = 8) (p < 0.03). Children with CF and with a history of respiratory symptoms (n = 31) had significantly higher functional residual capacity Z-scores (p < 0.02) and lower specific expiratory interrupter conductance Z-scores (p < 0.04). Genotype did not influence the data. We conclude that Rint(exp) and functional residual capacity measurements may help to follow young children with CF who are unable to perform reproducible forced expiratory maneuvers.]]></description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200205-421OC</identifier><identifier>PMID: 12379554</identifier><language>eng</language><publisher>New York, NY: Am Thoracic Soc</publisher><subject>Airway Resistance ; Biological and medical sciences ; Bronchodilator Agents - therapeutic use ; Child ; Child, Preschool ; Chronic obstructive pulmonary disease, asthma ; Cystic Fibrosis - drug therapy ; Cystic Fibrosis - genetics ; Cystic Fibrosis - physiopathology ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; Female ; Functional Residual Capacity ; Homozygote ; Humans ; Male ; Medical sciences ; Pneumology ; Respiratory Mechanics ; Tobacco Smoke Pollution - adverse effects</subject><ispartof>American journal of respiratory and critical care medicine, 2002-10, Vol.166 (8), p.1099-1104</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3</citedby><cites>FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13974924$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12379554$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beydon, Nicole</creatorcontrib><creatorcontrib>Amsallem, Francis</creatorcontrib><creatorcontrib>Bellet, Mireille</creatorcontrib><creatorcontrib>Boule, Michele</creatorcontrib><creatorcontrib>Chaussain, Michele</creatorcontrib><creatorcontrib>Denjean, Andre</creatorcontrib><creatorcontrib>Matran, Regis</creatorcontrib><creatorcontrib>Pin, Isabelle</creatorcontrib><creatorcontrib>Alberti, Corinne</creatorcontrib><creatorcontrib>Gaultier, Claude</creatorcontrib><title>Pulmonary Function Tests in Preschool Children with Cystic Fibrosis</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description><![CDATA[Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90-130 cm; 16 homozygous Delta F508) and in 79 healthy control children. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (Rint(exp)) (interrupter technique) were measured. As compared with control children, children with CF had significantly higher Rint(exp), expressed as absolute values and as Z-scores (1.05 +/- 0.36 versus 0.80 +/- 0.20 kPa.L(-1). second, p < 0.0001; and 1.31 +/- 1.72 versus 0.19 +/- 0.97, p < 0.0001), and significantly lower specific expiratory interrupter conductance (1.29 +/- 0.34 versus 1.63 +/- 0.43 kPa(-1). second, p < 0.0001). The effect of the bronchodilator salbutamol on Rint(exp) was not significantly different between children with CF and control children. Rint(exp) Z-scores were significantly higher in children with CF who were exposed to passive smoke (n = 8) (p < 0.03). Children with CF and with a history of respiratory symptoms (n = 31) had significantly higher functional residual capacity Z-scores (p < 0.02) and lower specific expiratory interrupter conductance Z-scores (p < 0.04). Genotype did not influence the data. We conclude that Rint(exp) and functional residual capacity measurements may help to follow young children with CF who are unable to perform reproducible forced expiratory maneuvers.]]></description><subject>Airway Resistance</subject><subject>Biological and medical sciences</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Cystic Fibrosis - drug therapy</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis - physiopathology</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>Female</subject><subject>Functional Residual Capacity</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pneumology</subject><subject>Respiratory Mechanics</subject><subject>Tobacco Smoke Pollution - adverse effects</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEQhoMotlZ_gBfJxYuwNdlks81RFqtCoT1U8Bay-XBT9qMkW0r_vVm30NPMwPPODA8AjxjNMWb01SvVzFOEUpQlNMXr4gpMcUbiwHN0HXuUk4RS_jMBdyHsEMLpAqNbMMEpyXmW0SkoNoe66VrpT3B5aFXvuhZuTegDdC3ceBNU1XU1LCpXa29aeHR9BYtT6J2CS1f6LrhwD26srIN5ONcZ-F6-b4vPZLX--CreVokinPSJlJohqzMpKVeWp4uMWGOYRjo3hueEYWpTjDjJWUZKLi2TVEeQGU1wSUoyA3jcq-LZ4I0Ve--a-LrASAxCxCBEjELEv5CYeRoz-0PZGH1JnA1E4PkMyKBkbb1slQsXjvCc8nTgXkaucr_V0XkjQiPrOq7FQu6Gw5gxsYivcE7-ACbleSM</recordid><startdate>20021015</startdate><enddate>20021015</enddate><creator>Beydon, Nicole</creator><creator>Amsallem, Francis</creator><creator>Bellet, Mireille</creator><creator>Boule, Michele</creator><creator>Chaussain, Michele</creator><creator>Denjean, Andre</creator><creator>Matran, Regis</creator><creator>Pin, Isabelle</creator><creator>Alberti, Corinne</creator><creator>Gaultier, Claude</creator><general>Am Thoracic Soc</general><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20021015</creationdate><title>Pulmonary Function Tests in Preschool Children with Cystic Fibrosis</title><author>Beydon, Nicole ; Amsallem, Francis ; Bellet, Mireille ; Boule, Michele ; Chaussain, Michele ; Denjean, Andre ; Matran, Regis ; Pin, Isabelle ; Alberti, Corinne ; Gaultier, Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Airway Resistance</topic><topic>Biological and medical sciences</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Cystic Fibrosis - drug therapy</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis - physiopathology</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>Female</topic><topic>Functional Residual Capacity</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pneumology</topic><topic>Respiratory Mechanics</topic><topic>Tobacco Smoke Pollution - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beydon, Nicole</creatorcontrib><creatorcontrib>Amsallem, Francis</creatorcontrib><creatorcontrib>Bellet, Mireille</creatorcontrib><creatorcontrib>Boule, Michele</creatorcontrib><creatorcontrib>Chaussain, Michele</creatorcontrib><creatorcontrib>Denjean, Andre</creatorcontrib><creatorcontrib>Matran, Regis</creatorcontrib><creatorcontrib>Pin, Isabelle</creatorcontrib><creatorcontrib>Alberti, Corinne</creatorcontrib><creatorcontrib>Gaultier, Claude</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beydon, Nicole</au><au>Amsallem, Francis</au><au>Bellet, Mireille</au><au>Boule, Michele</au><au>Chaussain, Michele</au><au>Denjean, Andre</au><au>Matran, Regis</au><au>Pin, Isabelle</au><au>Alberti, Corinne</au><au>Gaultier, Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary Function Tests in Preschool Children with Cystic Fibrosis</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2002-10-15</date><risdate>2002</risdate><volume>166</volume><issue>8</issue><spage>1099</spage><epage>1104</epage><pages>1099-1104</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract><![CDATA[Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis (CF). The objective of this multicenter study was to compare pulmonary function in 39 preschool children with CF (height, 90-130 cm; 16 homozygous Delta F508) and in 79 healthy control children. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (Rint(exp)) (interrupter technique) were measured. As compared with control children, children with CF had significantly higher Rint(exp), expressed as absolute values and as Z-scores (1.05 +/- 0.36 versus 0.80 +/- 0.20 kPa.L(-1). second, p < 0.0001; and 1.31 +/- 1.72 versus 0.19 +/- 0.97, p < 0.0001), and significantly lower specific expiratory interrupter conductance (1.29 +/- 0.34 versus 1.63 +/- 0.43 kPa(-1). second, p < 0.0001). The effect of the bronchodilator salbutamol on Rint(exp) was not significantly different between children with CF and control children. Rint(exp) Z-scores were significantly higher in children with CF who were exposed to passive smoke (n = 8) (p < 0.03). Children with CF and with a history of respiratory symptoms (n = 31) had significantly higher functional residual capacity Z-scores (p < 0.02) and lower specific expiratory interrupter conductance Z-scores (p < 0.04). Genotype did not influence the data. We conclude that Rint(exp) and functional residual capacity measurements may help to follow young children with CF who are unable to perform reproducible forced expiratory maneuvers.]]></abstract><cop>New York, NY</cop><pub>Am Thoracic Soc</pub><pmid>12379554</pmid><doi>10.1164/rccm.200205-421OC</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2002-10, Vol.166 (8), p.1099-1104
issn 1073-449X
1535-4970
language eng
recordid cdi_crossref_primary_10_1164_rccm_200205_421OC
source Freely Accessible Science Journals; EZB-FREE-00999 freely available EZB journals
subjects Airway Resistance
Biological and medical sciences
Bronchodilator Agents - therapeutic use
Child
Child, Preschool
Chronic obstructive pulmonary disease, asthma
Cystic Fibrosis - drug therapy
Cystic Fibrosis - genetics
Cystic Fibrosis - physiopathology
Cystic Fibrosis Transmembrane Conductance Regulator - genetics
Female
Functional Residual Capacity
Homozygote
Humans
Male
Medical sciences
Pneumology
Respiratory Mechanics
Tobacco Smoke Pollution - adverse effects
title Pulmonary Function Tests in Preschool Children with Cystic Fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A03%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20Function%20Tests%20in%20Preschool%20Children%20with%20Cystic%20Fibrosis&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Beydon,%20Nicole&rft.date=2002-10-15&rft.volume=166&rft.issue=8&rft.spage=1099&rft.epage=1104&rft.pages=1099-1104&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200205-421OC&rft_dat=%3Cpubmed_cross%3E12379554%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-aad60fd5aa49cf92853fee6d0d7ee973614f210937653b9af6a4dcf96ed31b3b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12379554&rfr_iscdi=true